WELLS FARGO & COMPANY/MN
Position in IOVA — Iovance Biotherapeutics, Inc.
CIK 72971
SAN FRANCISCO, CA
Position in IOVA
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$7,271,048
+$1,829,240 QoQ
Shares Held
2,071,524
+3.9% QoQ
Ownership
0.464%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 95.27714861136053.ToString("F0")%
Shared 0.ToString("F0")%
None 4.722851388639475.ToString("F0")%
Common Shares in IOVA Over Time
Shares Held
Position Value (USD)
Derivatives in IOVA
reported options exposure · as of Jun 30, 2020CallValue
$13,725
CallShares
500
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026WELLS FARGO & COMPANY/MN holds $1,292,861,286 across 390 Biotechnology names. IOVA ranks #26 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
744,995 | $332,670,066 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
342,763 | $113,409,991 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
142,021 | $109,731,102 | |
| 4 | HALO |
Halozyme Therapeutics, Inc.
|
1,535,737 | $99,254,679 | |
| 5 | INSM |
INSMED Inc
|
597,384 | $97,684,229 | |
| 6 | ASND |
Ascendis Pharma A/S
|
154,199 | $35,269,936 | |
| 7 | EXEL |
Exelixis, Inc.
|
687,304 | $29,478,466 | |
| 8 | ARGX |
Argenx SE
|
38,104 | $27,825,444 |
All Filings in IOVA
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $7,271,048 | 2,071,524 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $5,441,808 | 1,993,337 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $3,292,678 | 1,517,364 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $1,847,709 | 1,074,250 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $2,859,036 | 858,570 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $4,293,812 | 580,245 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $5,407,173 | 575,844 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $3,981,095 | 496,396 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $5,450,601 | 367,787 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $2,827,027 | 347,728 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $2,425,917 | 533,169 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $2,660,907 | 377,970 | Shares | Defined | 2023-08-15 | |
| 2023-03-31 | $1,514,771 | 247,917 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $241,483 | 37,791 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $558,704 | 58,320 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $307,450 | 27,849 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $867,897 | 52,126 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $1,067,548 | 55,922 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $1,218,054 | 49,394 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $1,445,825 | 55,566 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $1,923,470 | 60,754 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $3,351,935 | 72,240 | Shares | Defined | 2021-02-09 | |
| 2020-09-30 | $3,845,284 | 116,807 | Shares | Defined | 2020-11-05 | |
| 2020-06-30 | $4,489,802 | 163,563 | Shares | Defined | 2020-08-13 | |
| 2020-06-30 | $13,725 | 500 | Call | Defined | 2020-08-13 | |
| 2020-03-31 | $3,222,171 | 107,621 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||